Scoto, Mariacristina, Rossor, Alexander M, Harms, Matthew B, Cirak, Sebahattin, Calissano, Mattia, Robb, Stephanie, Manzur, Adnan Y, Martínez Arroyo, Amaia, Rodriguez Sanz, Aida, Mansour, Sahar, Fallon, Penny, Hadjikoumi, Irene, Klein, Andrea, Yang, Michele, De Visser, Marianne, Overweg-Plandsoen, W C G Truus, Baas, Frank, Taylor, J Paul, Benatar, Michael, Connolly, Anne M, Al-Lozi, Muhammad T, Nixon, John, de Goede, Christian G E L, Foley, A Reghan, Mcwilliam, Catherine, Pitt, Matthew, Sewry, Caroline, Phadke, Rahul, Hafezparast, Majid, Chong, W K Kling, Mercuri, Eugenio, Baloh, Robert H, Reilly, Mary M and Muntoni, Francesco (2015) Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy. Neurology, 84 (7). pp. 668-679. ISSN 1526-632X
This is the latest version of this item.
![]() |
PDF (Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy)
- Published Version
Download (1MB) |
Abstract
OBJECTIVE
To expand the clinical phenotype of autosomal dominant congenital spinal muscular atrophy with lower extremity predominance (SMA-LED) due to mutations in the dynein, cytoplasmic 1, heavy chain 1 (DYNC1H1) gene.
METHODS
Patients with a phenotype suggestive of a motor, non-length-dependent neuronopathy predominantly affecting the lower limbs were identified at participating neuromuscular centers and referred for targeted sequencing of DYNC1H1.
RESULTS
We report a cohort of 30 cases of SMA-LED from 16 families, carrying mutations in the tail and motor domains of DYNC1H1, including 10 novel mutations. These patients are characterized by congenital or childhood-onset lower limb wasting and weakness frequently associated with cognitive impairment. The clinical severity is variable, ranging from generalized arthrogryposis and inability to ambulate to exclusive and mild lower limb weakness. In many individuals with cognitive impairment (9/30 had cognitive impairment) who underwent brain MRI, there was an underlying structural malformation resulting in polymicrogyric appearance. The lower limb muscle MRI shows a distinctive pattern suggestive of denervation characterized by sparing and relative hypertrophy of the adductor longus and semitendinosus muscles at the thigh level, and diffuse involvement with relative sparing of the anterior-medial muscles at the calf level. Proximal muscle histopathology did not always show classic neurogenic features.
CONCLUSION
Our report expands the clinical spectrum of DYNC1H1-related SMA-LED to include generalized arthrogryposis. In addition, we report that the neurogenic peripheral pathology and the CNS neuronal migration defects are often associated, reinforcing the importance of DYNC1H1 in both central and peripheral neuronal functions.
Item Type: | Article |
---|---|
Schools and Departments: | School of Life Sciences > Neuroscience |
Depositing User: | Majid Hafezparast |
Date Deposited: | 15 Jan 2016 13:56 |
Last Modified: | 03 Jul 2019 00:18 |
URI: | http://sro.sussex.ac.uk/id/eprint/59198 |
Available Versions of this Item
-
Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy. (deposited 02 Feb 2015 19:27)
- Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophy. (deposited 15 Jan 2016 13:56) [Currently Displayed]
View download statistics for this item
📧 Request an update